Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 86.04% is in line with its 5-year average of 86.95%, near the low end of its 5-year range (85.33%–88.76%).
0.07% below its 12-month average of 86.10%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
86.04%
GROSS MARGIN AVG TTM
86.10%
GROSS MARGIN AVG 3Y
86.31%
GROSS MARGIN AVG 5Y
86.95%
GROSS MARGIN AVG 10Y
87.16%
GROSS MARGIN AVG 15Y
87.63%
GROSS MARGIN AVG 20Y
88.44%
CURRENT VS TTM AVG
-0.07%
CURRENT VS 3Y AVG
-0.32%
CURRENT VS 5Y AVG
-1.04%
CURRENT VS 10Y AVG
-1.28%
CURRENT VS 15Y AVG
-1.81%
CURRENT VS 20Y AVG
-2.71%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+45.84%
vs the sector median at left
Vertex Pharmaceuticals Incorporated
Market Cap
$132.44B
Gross Margin
86.04%
TTM Avg
86.10%
3Y Avg
86.31%
5Y Avg
86.95%
Market Cap
$131.94B
Gross Margin
70.16%
TTM Avg
63.94%
3Y Avg
60.40%
5Y Avg
58.39%
Market Cap
$124.38B
Gross Margin
66.68%
TTM Avg
66.73%
3Y Avg
66.82%
5Y Avg
67.04%
Market Cap
$143.23B
Gross Margin
58.51%
TTM Avg
60.22%
3Y Avg
59.98%
5Y Avg
59.48%
Market Cap
$104.57B
Gross Margin
65.17%
TTM Avg
62.91%
3Y Avg
61.66%
5Y Avg
61.70%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $132.44B | 86.04% | 86.10% | 86.31% | 86.95% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.94B | 70.16% | 63.94% | 60.40% | 58.39% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.38B | 66.68% | 66.73% | 66.82% | 67.04% |
| Danaher Corporation (DHR)vs › | $143.23B | 58.51% | 60.22% | 59.98% | 59.48% |
| CVS Health Corp. (CVS)vs › | $120.58B | 14.15% | 13.78% | 14.92% | 15.96% |
| Medtronic plc (MDT)vs › | $118.82B | 66.69% | 65.17% | 65.34% | 65.75% |
| Pfizer Inc. (PFE)vs › | $158.76B | 71.32% | 68.05% | 62.23% | 63.06% |
| McKesson Corporation (MCK)vs › | $104.70B | 3.64% | 3.54% | 3.83% | 4.16% |
| Stryker Corporation (SYK)vs › | $104.57B | 65.17% | 62.91% | 61.66% | 61.70% |
| Sanofi (SNY)vs › | $103.58B | 73.01% | 71.13% | 70.66% | 69.80% |
Gross Margin
86.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 85.33% |
| 2026-03-31 | 86.85% |
| 2025-12-31 | 85.56% |
| 2025-09-30 | 86.52% |
| 2025-06-30 | 86.25% |
| 2025-03-31 | 86.90% |
| 2024-12-31 | 85.46% |
| 2024-09-30 | 85.84% |
| 2024-06-30 | 85.94% |
| 2024-03-31 | 87.25% |
| 2023-12-31 | 85.38% |
| 2023-09-30 | 87.17% |
| 2023-06-30 | 87.62% |
| 2023-03-31 | 88.76% |
| 2022-12-31 | 87.70% |
| 2022-09-30 | 87.60% |
| 2022-06-30 | 88.08% |
| 2022-03-31 | 88.28% |
| 2021-12-31 | 88.06% |
| 2021-09-30 | 88.08% |
| 2021-06-30 | 87.29% |
| 2021-03-31 | 88.85% |
| 2020-12-31 | 87.52% |
| 2020-09-30 | 87.90% |
| 2020-06-30 | 87.90% |
| 2020-03-31 | 89.27% |
| 2019-12-31 | 86.91% |
| 2019-09-30 | 86.11% |
| 2019-06-30 | 85.58% |
| 2019-03-31 | 88.92% |
| 2018-12-31 | 85.95% |
| 2018-09-30 | 85.82% |
| 2018-06-30 | 86.12% |
| 2018-03-31 | 88.82% |
| 2017-12-31 | 87.10% |
| 2017-09-30 | 87.40% |
| 2017-06-30 | 86.91% |
| 2017-03-31 | 93.43% |
| 2016-12-31 | 86.81% |
| 2016-09-30 | 86.93% |
| 2016-06-30 | 89.52% |
| 2016-03-31 | 87.28% |
| 2015-12-31 | 84.59% |
| 2015-09-30 | 89.68% |
| 2015-06-30 | 89.85% |
| 2015-03-31 | 91.11% |
| 2014-12-31 | 90.30% |
| 2014-09-30 | 92.08% |
| 2014-06-30 | 87.50% |
| 2014-03-31 | 86.93% |
| 2013-12-31 | 93.66% |
| 2013-09-30 | 87.67% |
| 2013-06-30 | 87.79% |
| 2013-03-31 | 86.98% |
| 2012-12-31 | 73.74% |
| 2012-09-30 | 88.53% |
| 2012-06-30 | 72.65% |
| 2012-03-31 | 91.06% |
| 2011-12-31 | 94.65% |
| 2011-09-30 | 94.17% |
| 2011-06-30 | 91.87% |
| 2011-03-31 | 96.38% |
| 2010-12-31 | 95.35% |
| 2010-09-30 | 86.43% |
| 2010-06-30 | 90.24% |
| 2010-03-31 | 84.99% |
| 2009-12-31 | 89.24% |
| 2009-09-30 | 85.13% |
| 2009-06-30 | 82.86% |
| 2009-03-31 | 85.09% |
| 2008-12-31 | 87.15% |
| 2008-09-30 | 86.73% |
| 2008-06-30 | 94.67% |
| 2008-03-31 | 91.42% |
| 2007-12-31 | 92.80% |
| 2007-09-30 | 91.32% |
| 2007-06-30 | 91.10% |
| 2007-03-31 | 95.25% |
| 2006-12-31 | 96.63% |
| 2006-09-30 | 94.16% |
| 2006-06-30 | 90.29% |
| 2006-03-31 | 92.34% |
| 2005-12-31 | 95.63% |
| 2005-09-30 | 92.28% |
| 2005-06-30 | 92.30% |
| 2005-03-31 | 92.90% |
| 2004-12-31 | 94.96% |
| 2004-09-30 | 94.54% |
| 2004-06-30 | 92.84% |
| 2004-03-31 | 95.17% |
| 2003-12-31 | 139.89% |
| 2003-09-30 | 91.00% |
| 2003-06-30 | 91.25% |
| 2003-03-31 | 84.45% |
| 2002-12-31 | 84.92% |
| 2002-09-30 | 80.81% |
